Navigation Links
Researcher working on destruction of chemical weapons
Date:9/24/2008

COLLEGE STATION, Sept. 24, 2008 America's war on terror includes fighting the dark side of deadly chemical agents, and Texas A&M University chemist Dr. Frank Raushel is helping with the fight by developing an enzyme that might neutralize one such chemical agent, the organophosphates.

Synthetic organophosphates started their journey as insecticides in the 1930s but soon made their way into the dangerous alleys of chemical warfare during World War II. Raushel, who has been working on detoxification of organophosphates for nearly 10 years, says that the toxic properties of the organophosphate nerve agents are a serious threat to the health and well being of civilized societies.

Although outlawed by several international treaties, some countries have used chemical agents during times of war. In 1988, the Iraqi Kurdish village of Halabja was exposed to multiple chemical agents, killing about 5,000 of the town's 50,000 residents. After the incident, traces of mustard gas and the organophosphates sarin, tabun and VX were discovered.

Raushel, the Davidson Professor of Science at Texas A&M, has been awarded a four-year grant of $1.2 million by the National Institutes of Health to carry out his work on organophosphates.

Organophosphates are neurotoxins they attack the nervous system by blocking the function of the enzyme acetylcholine esterase, which carries nerve signals. When organs such as the lungs do not receive appropriate nerve signals, control is lost over respiratory muscles, and it usually results in death by asphyxiation. Today, some classes of organophosphates are used as insecticides while others have been categorized as chemical weapons.

Researchers have discovered a bacterial enzyme, phosphotriesterase, which can recognize and destroy the toxicity of a broad spectrum of organophosphate nerve agents. What Raushel aims to do is design and characterize bacterial phosphotriesterases that are better at detecting, destroying and detoxifying those organophosphates that pose the most serious threats to human health.


'/>"/>

Contact: Dr. Frank Raushel
raushel@mail.chem.tamu.edu
979-845-3373
Texas A&M University
Source:Eurekalert

Related biology news :

1. Researchers note differences between people and animals on calorie restriction
2. Researchers find an essential gene for forming ears of corn
3. Researchers find animal with ability to survive climate change
4. NC State researchers get to root of parasite genome
5. Wistar Institute researcher receives New Innovator award from NIH
6. UC Davis researchers discover new drug target for inflammatory disease
7. Pittsburgh researchers identify source of multipotent stem cells with broad regenerative potential
8. U of M researchers identify gene linked to common ailment in labrador retrievers
9. Friendly bacteria protect against type 1 diabetes, Yale researchers find
10. Using novel tool, UD researchers dig through cell trash and find treasure
11. More than skin deep: Theres no such thing as a safe suntan, researchers warn
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... 2016 On Monday, the Department of Homeland ... share solutions for the Biometric Exit Program. The Request ... Protection (CBP), explains that CBP intends to add biometrics ... the United States , in order to deter ... Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
(Date:6/9/2016)... leader in attendance control systems is proud to announce the introduction of fingerprint attendance ... the right employees are actually signing in, and to even control the opening of ... ... ... Photo - ...
(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016   EpiBiome , a precision microbiome engineering ... debt financing from Silicon Valley Bank (SVB). The financing ... advance its drug development efforts, as well as purchase ... "SVB has been an incredible strategic partner to us ... bank would provide," said Dr. Aeron Tynes Hammack ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free validated ... will showcase its product’s latest features from June 26 to June 30, 2016 ... on Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug ...
(Date:6/23/2016)... , June 23, 2016 ... market research report to its pharmaceuticals section with ... product details and much more. Complete ... across 151 pages, profiling 15 companies and supported ... at http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The ...
Breaking Biology Technology: